Bali Muralidhar
Director/Board Member bei RENEO PHARMACEUTICALS, INC.
Vermögen: 140 $ am 31.03.2024
Profil
Bali Muralidhar is currently a Director at Gynesonics, Inc., Dassiet Oy, NuCana Plc, Exicure Operating Co., Reneo Pharmaceuticals, Inc., Spruce Biosciences, Inc., Wugen, Inc., Anjarium Biosciences AG, Stryve Online Ltd., Launch Therapeutics, Inc., and Abingworth LLP.
He previously worked as a Director at ZipLine Medical, Inc., Wilson Therapeutics AB, Exicure, Inc., and Valneva SE.
He also served as a Member of the Healthcare Deal Department at Bain Capital LP and as a Senior Partner at MVM Partners LLP.
Dr. Muralidhar holds a doctorate degree from the University of Oxford and the University of Cambridge.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUCANA PLC
0,00% | 31.12.2023 | 540 ( 0,00% ) | 140 $ | 31.03.2024 |
| 06.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 | |
SPRUCE BIOSCIENCES, INC.
-.--% | 25.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Bali Muralidhar
| Unternehmen | Position | Beginn |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Director/Board Member | 01.02.2020 |
| NUCANA PLC | Director/Board Member | 13.10.2020 |
| RENEO PHARMACEUTICALS, INC. | Director/Board Member | 01.04.2021 |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Director/Board Member | 01.08.2019 |
Anjarium Biosciences AG
 Anjarium Biosciences AG BiotechnologyHealth Technology Anjarium Biosciences AG is a Swiss company that focuses on creating a new class of non-viral gene therapies to tackle genetic diseases throughout a patient's lifetime. The company is based in Schlieren, Switzerland. The company's versatile platform leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology, and nanoparticle engineering to generate a pipeline of advanced gene therapies with unique competitive advantages over current viral-vector based gene therapies. Anjarium's investors include leading international and strategic investors such as Abingworth, Gimv, Omega Funds, Pfizer Ventures, and Surveyor Capital. The company was founded by Joël de Beer, and Stephen Yoo has been the CEO of the company since 2022. | Director/Board Member | - |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Director/Board Member | - |
Gynesonics, Inc.
 Gynesonics, Inc. Medical SpecialtiesHealth Technology Gynesonics, Inc. provides medical devices for women's health. It offers VizAblate System for the transcervical treatment of symptomatic uterine fibroids under intrauterine ultrasound guidance. The company was founded by Jessica grossman in 2005 and is headquartered in Redwood City, CA. | Director/Board Member | - |
Stryve Online Ltd.
 Stryve Online Ltd. Miscellaneous Commercial ServicesCommercial Services Stryve Online Ltd. is a British company that offers an applicant tracking system designed to improve the hiring process. The company is based in London, UK. The platform is equipped with various features that aim to make the process more efficient. It was founded in 2019 by Edward Chamberlain. | Director/Board Member | - |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. | Chief Investment Officer | 01.08.2022 |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ehemalige bekannte Positionen von Bali Muralidhar
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Bali Muralidhar
| University of Oxford | Doctorate Degree |
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| NUCANA PLC | Health Technology |
| VALNEVA | Health Technology |
| RENEO PHARMACEUTICALS, INC. | Health Technology |
| EXICURE, INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Gynesonics, Inc.
Gynesonics, Inc. Medical SpecialtiesHealth Technology Gynesonics, Inc. provides medical devices for women's health. It offers VizAblate System for the transcervical treatment of symptomatic uterine fibroids under intrauterine ultrasound guidance. The company was founded by Jessica grossman in 2005 and is headquartered in Redwood City, CA. | Health Technology |
ZipLine Medical, Inc.
 ZipLine Medical, Inc. Medical SpecialtiesHealth Technology ZipLine Medical, Inc. engages in the development of non-invasive surgical skin closure devices. It offers Zip Surgical,m PreLoc Wound Care, and Zipstitch Consumer platforms. The company was founded by Amir Belson in 2009 and is headquartered in Campbell, CA. | Health Technology |
Bain Capital LP
 Bain Capital LP Financial ConglomeratesFinance Bain Capital LP engages in provision of investment consulting services. It specializes in private equity, credit, public equity, venture, real estate, double impact, life sciences, and partnership strategies. The company was founded in 1984 and is headquartered in Boston, MA. | Finance |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth LLP is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. | Finance |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Finance |
Dassiet Oy
 Dassiet Oy Medical SpecialtiesHealth Technology Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland. | Health Technology |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Technology Services |
Anjarium Biosciences AG
Anjarium Biosciences AG BiotechnologyHealth Technology Anjarium Biosciences AG is a Swiss company that focuses on creating a new class of non-viral gene therapies to tackle genetic diseases throughout a patient's lifetime. The company is based in Schlieren, Switzerland. The company's versatile platform leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology, and nanoparticle engineering to generate a pipeline of advanced gene therapies with unique competitive advantages over current viral-vector based gene therapies. Anjarium's investors include leading international and strategic investors such as Abingworth, Gimv, Omega Funds, Pfizer Ventures, and Surveyor Capital. The company was founded by Joël de Beer, and Stephen Yoo has been the CEO of the company since 2022. | Health Technology |
Stryve Online Ltd.
Stryve Online Ltd. Miscellaneous Commercial ServicesCommercial Services Stryve Online Ltd. is a British company that offers an applicant tracking system designed to improve the hiring process. The company is based in London, UK. The platform is equipped with various features that aim to make the process more efficient. It was founded in 2019 by Edward Chamberlain. | Commercial Services |
Launch Therapeutics, Inc.
 Launch Therapeutics, Inc. Financial ConglomeratesFinance Launch Therapeutics, Inc. provides investment and therapies development services. The CEO of the American company is Anshul Thakral. | Finance |
